A business in context
PRGO research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-11 | Parker Geoffrey M. | F · Tax / exercise payment | Ordinary Shares | 607.0 | 13.66 |
| 2026-09-11 | Parker Geoffrey M. | M · Exercise / conversion | Ordinary Shares | 1263.0 | 13.66 |
| 2026-09-11 | Parker Geoffrey M. | M · Exercise / conversion | Restricted Stock Units | 1263.0 | n/a |
| 2026-09-11 | Alford Bradley A | F · Tax / exercise payment | Ordinary Shares | 607.0 | 13.66 |
| 2026-09-11 | Alford Bradley A | M · Exercise / conversion | Ordinary Shares | 1263.0 | 13.66 |
| 2026-09-11 | Alford Bradley A | M · Exercise / conversion | Restricted Stock Units | 1263.0 | n/a |
| 2026-09-11 | Alford Bradley A | A · Grant / award | Restricted Stock Units | 2059.0 | n/a |
| 2026-09-09 | Ball David | M · Exercise / conversion | Ordinary Shares | 7701.0 | 14.34 |
| 2026-09-09 | Ball David | F · Tax / exercise payment | Ordinary Shares | 2784.0 | 14.34 |
| 2026-09-09 | Ball David | M · Exercise / conversion | Restricted Stock Units | 7701.0 | n/a |
| 2026-07-08 | Manzone Albert | A · Grant / award | Restricted Stock Units | 235627.0 | n/a |
| 2026-07-08 | Amin Ahmed Salman | A · Grant / award | Restricted Stock Units | 14964.0 | n/a |
| 2026-07-08 | Gajial Muhammad Omer | A · Grant / award | Restricted Stock Units | 14964.0 | n/a |
| 2026-07-08 | Bezerra Eduardo Guarita | A · Grant / award | Restricted Stock Units | 141376.0 | n/a |
| 2026-07-08 | Khoury Roberto | A · Grant / award | Restricted Stock Units | 113101.0 | n/a |
| 2026-07-08 | Ball David | A · Grant / award | Restricted Stock Units | 70688.0 | n/a |
| 2026-07-08 | Atkinson Charles | A · Grant / award | Restricted Stock Units | 123704.0 | n/a |
| 2026-07-08 | Winterman Matthew John | A · Grant / award | Restricted Stock Units | 70688.0 | n/a |
| 2026-07-08 | Willis Robert | A · Grant / award | Restricted Stock Units | 60085.0 | n/a |
| 2026-07-08 | Lennox Abigail | A · Grant / award | Restricted Stock Units | 84826.0 | n/a |
| 2026-07-08 | Winterman Matthew John | F · Tax / exercise payment | Ordinary Shares | 963.0 | 10.52 |
| 2026-07-08 | Winterman Matthew John | M · Exercise / conversion | Ordinary Shares | 15660.0 | 10.52 |
| 2026-07-08 | Winterman Matthew John | F · Tax / exercise payment | Ordinary Shares | 8175.0 | 10.52 |
| 2026-07-08 | Winterman Matthew John | M · Exercise / conversion | Ordinary Shares | 1843.0 | 10.52 |
| 2026-07-08 | Winterman Matthew John | M · Exercise / conversion | Restricted Stock Units | 15660.0 | n/a |
| 2026-07-08 | Winterman Matthew John | M · Exercise / conversion | Restricted Stock Units | 1843.0 | n/a |
| 2026-07-08 | Khoury Roberto | F · Tax / exercise payment | Ordinary Shares | 385.0 | 10.52 |
| 2026-07-08 | Khoury Roberto | M · Exercise / conversion | Ordinary Shares | 737.0 | 10.52 |
| 2026-07-08 | Khoury Roberto | M · Exercise / conversion | Restricted Stock Units | 737.0 | n/a |
Identity & relationships
SEC issuer · 0001585364PERRIGO Co plc
Perrigo Company plcPerrigo (Israel)Perrigo (United States)Perrigo (Sweden)Perrigo (Germany)
Search names and former names
View Wikidata identity and references ↗
- Perrigo Company plc · subsidiary · wikidata
- Perrigo Pharmaceutical · alias · wikidata
- Perrigo Company · alias · wikidata
- PRGO · alias · wikidata
- Perrigo (Israel) · subsidiary · wikidata
- Perrigo (United States) · subsidiary · wikidata
- Perrigo (Sweden) · subsidiary · wikidata
- Élan · subsidiary · wikidata
- Elan · subsidiary · wikidata
- Perrigo (Germany) · subsidiary · wikidata
- PERRIGO Co Ltd · former SEC name · 2013-08-28 to 2013-11-12
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $4.37B | $4.70B |
| 2023-12-31 | $4.66B | $5.15B |
| 2022-12-31 | $4.45B | $5.12B |
| 2021-12-31 | $4.14B | $5.15B |
| 2020-12-31 | $4.09B | $5.32B |
| 2019-12-31 | $3.87B | $5.10B |
| 2018-12-31 | $4.73B | $6.35B |
| 2017-12-31 | $4.95B | $6.80B |